Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 9069375, 7 pages
http://dx.doi.org/10.1155/2016/9069375
Review Article

Clinical Relevance of HLA Gene Variants in HBV Infection

1Infectious Disease Hospital of Yantai, 62 Huanshan Road, Zhifu District, Yantai, Shandong 264001, China
2Hepatology Department, Qilu Hospital of Shandong University, 44 Wenhua West Road, Lixia District, Jinan, Shandong 250012, China

Received 22 February 2016; Accepted 14 April 2016

Academic Editor: Oscar Bottasso

Copyright © 2016 Li Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Little and P. Parham, “Polymorphism and evolution of HLA class I and II genes and molecules,” Reviews in immunogenetics, vol. 1, no. 1, pp. 105–123, 1999. View at Google Scholar · View at Scopus
  2. X. Chen, W. Wang, S. Wang et al., “An immunodominant HLA-A1101-restricted CD8+ T-cell response targeting hepatitis B surface antigen in chronic hepatitis B patients,” Journal of General Virology, vol. 94, part 12, pp. 2717–2723, 2013. View at Google Scholar
  3. Q. Liu, Y. Zheng, Y. Yu, Q. Tan, and X. Huang, “Identification of HLA-A0201-restricted CD8+ T-cell epitope C64-72 from hepatitis B virus core protein,” International Immunopharmacology, vol. 13, no. 2, pp. 141–147, 2012. View at Publisher · View at Google Scholar
  4. A. T. Tan, E. Loggi, C. Boni et al., “Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire,” Journal of Virology, vol. 82, no. 22, pp. 10986–10997, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Miao, H. Sun, N. Pan et al., “Association of human leukocyte antigen class i polymorphism with spontaneous clearance of hepatitis b surface antigen in qidong han population,” Clinical and Developmental Immunology, vol. 2013, Article ID 145725, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Guo, Y. Zhang, J. Li et al., “Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population,” Hepatology, vol. 53, no. 2, pp. 422–428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Matsuura, M. Isogawa, and Y. Tanaka, “Host genetic variants influencing the clinical course of Hepatitis B virus infection,” Journal of Medical Virology, vol. 88, no. 3, pp. 371–379, 2016. View at Google Scholar
  8. Y. Zhang, F. Zhao, L. Lan, Z. Qin, and L. Jun, “Correlation of HLA-DQB1 gene polymorphism of Xinjiang Uygur with outcome of HBV infection,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 4, pp. 6067–6072, 2015. View at Google Scholar · View at Scopus
  9. B. D. M. Corrêa, E. P. D. A. Lopes, M. D. F. P. M. de Albuquerque, and L. Dourado, “Association between HLA-DRB1 polymorphisms and hepatitis B infection in a Brazilian population,” Revista da Associacao Medica Brasileira, vol. 58, no. 5, pp. 537–542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Hu, X. Zhai, J. Liu et al., “Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development,” Hepatology, vol. 55, no. 5, pp. 1426–1431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. W.-K. Seto, D. K.-H. Wong, M. Kopaniszen et al., “HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B,” Clinical Infectious Diseases, vol. 56, no. 12, pp. 1695–1703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Hu, J. Yang, G. Xiong et al., “HLA-DPB1 variant effect on hepatitis B virus clearance and liver cirrhosis development among Southwest Chinese population,” Hepatitis Monthly, vol. 14, no. 8, Article ID e19747, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Zhang, C. Zheng, Z. H. Zhou et al., “Relationship between HLA-DP gene polymorphisms and the risk of hepatocellular carcinoma: a meta-analysis,” Genetics and Molecular Research, vol. 14, no. 4, pp. 15553–15563, 2015. View at Publisher · View at Google Scholar
  14. R. Singh, R. Kaul, A. Kaul, and K. Khan, “A comparative review of HLA associations with hepatitis B and C viral infections across global populations,” World Journal of Gastroenterology, vol. 13, no. 12, pp. 1770–1787, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Thomas, C. L. Thio, R. Apps et al., “A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection,” Journal of Virology, vol. 86, no. 12, pp. 6979–6985, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Zhu, J. Dai, C. Wang et al., “Fine mapping the MHC region identified four independent variants modifying susceptibility to Chronic Hepatitis B in Han Chinese,” Human Molecular Genetics, vol. 25, no. 6, pp. 1225–1232, 2016. View at Publisher · View at Google Scholar
  17. J. Tao, K. Su, C. Yu et al., “Fine mapping analysis of HLA-DP/DQ gene clusters on chromosome 6 reveals multiple susceptibility loci for HBV infection,” Amino Acids, vol. 47, no. 12, pp. 2623–2634, 2015. View at Publisher · View at Google Scholar
  18. S.-W. Chang, C. S.-J. Fann, W.-H. Su et al., “A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese,” PLoS ONE, vol. 9, no. 6, Article ID e99724, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Nishida, H. Sawai, K. Kashiwase et al., “New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia,” PLoS ONE, vol. 9, no. 2, Article ID e86449, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. C. L. Thio, M. Carrington, D. Marti et al., “Class II HLA alleles and hepatitis B virus persistence in African Americans,” Journal of Infectious Diseases, vol. 179, no. 4, pp. 1004–1006, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. A. A. Al-Qahtani, M. R. Al-Anazi, A. A. Abdo et al., “Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients,” PLoS ONE, vol. 9, no. 1, Article ID e80445, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. K.-C. Lau, C.-W. Lam, C.-Y. Law et al., “Non-invasive screening of HLA-DPA1 and HLA-DPB1 alleles for persistent hepatitis B virus infection: susceptibility for vertical transmission and toward a personalized approach for vaccination and treatment,” Clinica Chimica Acta, vol. 412, no. 11-12, pp. 952–957, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-Y. Xu, J.-Y. Yu, Y.-W. Zhong et al., “Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus,” International Journal of Biological Sciences, vol. 4, no. 2, pp. 111–115, 2008. View at Google Scholar · View at Scopus
  24. M. R. Thursz, D. Kwiatkowski, C. E. M. Allsopp, B. M. Greenwood, H. C. Thomas, and A. V. S. Hill, “Association between an MHC class II allele and clearance of hepatitis B virus in the gambia,” The New England Journal of Medicine, vol. 332, no. 16, pp. 1065–1069, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Höhler, G. Gerken, A. Notghi et al., “HLA-DRB11301 and 1302 protect against chronic hepatitis B,” Journal of Hepatology, vol. 26, no. 3, pp. 503–507, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. S. H. Ahn, K.-H. Han, J. Y. Park et al., “Association between hepatitis B virus infection and HLA-DR type in Korea,” Hepatology, vol. 31, no. 6, pp. 1371–1373, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Wang, X.-P. Wu, W. Zhang et al., “Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies,” PLoS ONE, vol. 6, no. 3, Article ID e17608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Vermehren, J. Lötsch, S. Susser et al., “A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers,” PLoS ONE, vol. 7, no. 3, Article ID e32605, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Mohamadkhani, A. Katoonizadeh, and H. Poustchi, “Immune-regulatory events in the clearance of HBsAg in chronic hepatitis B: focuses on HLA-DP,” Middle East Journal of Digestive Diseases, vol. 7, no. 1, pp. 5–13, 2015. View at Google Scholar
  30. P. Kummee, P. Tangkijvanich, Y. Poovorawan, and N. Hirankarn, “Association of HLA-DRB113 and TNF-α gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population,” Journal of Viral Hepatitis, vol. 14, no. 12, pp. 841–848, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. Z.-H. Yan, Y. Fan, X.-H. Wang, Q. Mao, G.-H. Deng, and Y.-M. Wang, “Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis,” World Journal of Gastroenterology, vol. 18, no. 24, pp. 3119–3128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H.-R. Cheng, C.-J. Liu, T.-C. Tseng et al., “Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients,” PLoS ONE, vol. 8, no. 1, Article ID e53008, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. T. R. O'Brien, I. Kohaar, R. M. Pfeiffer et al., “Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver,” Genes and Immunity, vol. 12, no. 6, pp. 428–433, 2011. View at Publisher · View at Google Scholar
  34. L. Yu, Y.-J. Cheng, M.-L. Cheng et al., “Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development,” Scientific Reports, vol. 5, Article ID 14933, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Li, W. Liu, H. Wang et al., “The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China,” Virus Research, vol. 163, no. 1, pp. 328–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Almarri and J. R. Batchelor, “HLA and hepatitis B infection,” The Lancet, vol. 344, no. 8931, pp. 1194–1195, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-F. Wu, L.-Y. Wang, T.-D. Lee et al., “HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan,” Journal of Medical Virology, vol. 72, no. 1, pp. 17–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. S. L. Zhang, M. Liu, J. Zhu, and N. L. Chai, “Predominant Th-2 immune response and chronic hepatitis B virus infection,” Shijie Huaren Xiaohua Zazhi, vol. 7, pp. 513–515, 1999. View at Google Scholar
  39. W. N. Chen and C. J. Oon, “Mutation ‘hot spot’ in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma,” Biochemical and Biophysical Research Communications, vol. 262, no. 3, pp. 757–761, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Cotrina, M. Buti, R. Jardí et al., “Study of HLA-II antigens in chronic hepatitis C and B and in acute hepatitis B,” Gastroenterología y Hepatología, vol. 20, no. 3, pp. 115–118, 1997. View at Google Scholar · View at Scopus
  41. X. Zhang, J. Jia, J. Dong et al., “HLA-DQ polymorphisms with HBV infection: Different outcomes upon infection and prognosis to lamivudine therapy,” Journal of Viral Hepatitis, vol. 21, no. 7, pp. 491–498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Lin, H. Zou, and S. Wang, “Hepatitis B e antigen seroconversion is related with the function of dendritic cells in chronic hepatitis b virus infection,” Gastroenterology Research and Practice, vol. 2014, Article ID 413952, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. J.-F. Wu, C.-H. Chen, R.-P. Hsieh et al., “HLA typing associated with hepatitis B E antigen seroconversion in children with chronic hepatitis B virus infection: a long-term prospective sibling cohort study in Taiwan,” Journal of Pediatrics, vol. 148, no. 5, pp. 647–651, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Komatsu, J. Murakami, A. Inui, T. Tsunoda, T. Sogo, and T. Fujisawa, “Association between single-nucleotide polymorphisms and early spontaneous hepatitis B virus e antigen seroconversion in children,” BMC Research Notes, vol. 7, article 789, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. P. C. Matthews, J. M. Carlson, A. Beloukas et al., “HLA-A is a predictor of hepatitis B e antigen status in HIV-positive African adults,” The Journal of Infectious Diseases, vol. 213, no. 8, pp. 1248–1252, 2016. View at Publisher · View at Google Scholar
  46. D. K. Jiang, X. P. Ma, X. Wu et al., “Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis,” Scientific Reports, vol. 5, Article ID 16278, 2015. View at Publisher · View at Google Scholar
  47. S. Li, J. Qian, Y. Yang et al., “GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitisB virus carriers,” PLoS Genetics, vol. 8, no. 7, Article ID e1002791, 2012. View at Publisher · View at Google Scholar
  48. D.-K. Jiang, J. Sun, G. Cao et al., “Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma,” Nature Genetics, vol. 45, no. 1, pp. 72–75, 2013. View at Publisher · View at Google Scholar
  49. J. Wen, C. Song, D. Jiang et al., “Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study,” Scientific Reports, vol. 5, Article ID 16489, 2015. View at Publisher · View at Google Scholar
  50. J. Zhang, L. Pan, L. Chen, X. Feng, L. Zhou, and S. Zheng, “Non-classical MHC-Ι genes in chronic hepatitis B and hepatocellular carcinoma,” Immunogenetics, vol. 64, no. 3, pp. 251–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Doganay, A. Fejzullahu, S. Katrinli et al., “Association of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B,” World Journal of Gastroenterology, vol. 20, no. 25, pp. 8179–8186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Liao, B. Cai, Y. Li et al., “Association of HLA-DP/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis,” PLoS ONE, vol. 9, no. 11, Article ID e111677, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Pan, J. Qiu, H. Sun et al., “Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection,” Clinical and Developmental Immunology, vol. 2013, Article ID 874514, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Pan, W. Jiang, H. Sun et al., “KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study,” PLoS ONE, vol. 6, no. 10, Article ID e25682, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. W. P. Brouwer, M. J. Sonneveld, F. Tabak et al., “Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B,” Alimentary Pharmacology and Therapeutics, vol. 40, no. 7, pp. 811–818, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. Y.-N. Han, J.-L. Yang, S.-G. Zhen, Q. Tang, and W. Zhu, “Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients,” World Journal of Gastroenterology, vol. 11, no. 36, pp. 5721–5724, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Cheng, X. Sun, S. Tan et al., “Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients,” Hepatology Research, vol. 44, no. 9, pp. 1000–1007, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. T.-C. Tseng, M.-L. Yu, C.-J. Liu et al., “Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy,” Antiviral Therapy, vol. 16, no. 5, pp. 629–637, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Hosaka, F. Suzuki, M. Kobayashi et al., “HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy,” Liver International, vol. 35, no. 4, pp. 1290–1302, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. Y.-J. Jin, J. H. Shim, Y.-H. Chung et al., “HLA-DRB1*010101 allele is closely associated with poor virological response to lamivudine therapy in patients with chronic hepatitis B,” Digestion, vol. 84, no. 1, pp. 35–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Tangkijvanich, S. Chittmittraprap, K. Poovorawan et al., “A randomized clinical trial of peginterferon alpha-2b with or without entecavir in patients with HBeAg-negative chronic hepatitis B: role of host and viral factors associated with treatment response,” Journal of Viral Hepatitis, vol. 23, no. 6, pp. 427–438, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. Z.-K. Li, J.-J. Nie, J. Li, and H. Zhuang, “The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis,” Vaccine, vol. 31, no. 40, pp. 4355–4361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Mert, A. Sengul, H. C. Gul, A. Karakas, and C. P. Eyigun, “The role of human leukocyte antigen tissue groups in hepatitis B virus vaccination in Turkey,” Journal of Microbiology, Immunology and Infection, vol. 47, no. 1, pp. 9–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. J. H. Yoon, S. Shin, J. W. In, J. Y. Chang, E. Y. Song, and E. Y. Roh, “Association of HLA alleles with the responsiveness to hepatitis B virus vaccination in Korean infants,” Vaccine, vol. 32, no. 43, pp. 5638–5644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Zeng, T. Gao, G. Zhao et al., “Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation,” Human Vaccines & Immunotherapeutics, vol. 19, 2015. View at Google Scholar
  66. S.-H. Hou, J. Hu, Y. Zhang, Q.-L. Li, and J.-J. Guo, “Effects of interaction between genetic variants in human leukocyte antigen DQ and granulysin genes in Chinese Han subjects infected with hepatitis B virus,” Microbiology and Immunology, vol. 59, no. 4, pp. 209–218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. D. He, S. Tao, S. Guo et al., “Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese,” Liver International, vol. 35, no. 8, pp. 1941–1949, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. X. Ji, Q. Zhang, B. Li et al., “Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma,” Infection, Genetics and Evolution, vol. 28, pp. 201–209, 2014. View at Publisher · View at Google Scholar · View at Scopus